ALNY vs KRMN · P/E 76, rev $1.29B vs P/E 225, rev $471.5M
Alnylam Pharmaceuticals Inc (ALNY) versus Karman Holdings Inc. (KRMN) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Karman Holdings Inc. (KRMN) is a aerospace & defense company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported KRMN revenue for 2025-12-31 was $471.5M. Net income was $17.4M. Revenue was up 36.6% from 2024-12-31 to 2025-12-31. KRMN currently screens at market cap $6.87B and trailing P/E 225.4.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. KRMN currently screens at market cap $6.87B and trailing P/E 225.4.
Not investment advice. Open the ALNY and KRMN stock pages for the full models.
Not investment advice.